「iii」の検索結果
76件：36～40件目を表示
もしかして
-
ve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 clinical trial*2 ) successfully met the prim...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
ve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 clinical trial*2 ) successfully met the prim...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
ve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial conducted by Senju (Study Name: 3-02 Clinical Trial*2) successfully met the prima...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
お知らせ | 千寿製薬株式会社
6, 2024 Launch of Distribution of RET-700（PDF） July 16, 2024 Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132（PDF） July 8, 2024 Not...
http://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
24年07月26日 Launch of Distribution of RET-700（PDF） 2024年07月16日 Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132（PDF） 2024年07月08日 Noti...
http://www.senju.co.jp/chinese/news/